Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Radiation Injuries × Daclizumab × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma 2 Radiation Injuries 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hodgkin Disease 1

Interventions

Radiotherapy 1 Pentetic Acid 1 Ifosfamide 1 Filgrastim 1 Fibroblast Growth Factor 7 1 Etoposide 1 Daclizumab 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00019227 2013-06-20

Monoclonal Antibody Therapy in Treating Patients With Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Radiation Injuries, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡